2026-10-25
Braiin clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 28,180 +0.68%
S&P 7,569 +0.36%
GOLD $4,026 +2.18%
BTC $77,978 +0.82%
VIX 20.83 −1.51%
latest tape · as of 07:18 UTC
The Screen · Technology · Computer Hardware
Braiin Limited
BRAI · Nasdaq · USD · Market cap $847M · 5 employees
Braiin Limited operates as an agriculture and analytics services company that provides solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software, and AI/ML in Australia and New Zealand.
Not yet scored3.07 USD
Price as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 07:18 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.07 USD at the 3 Nov 2026 close
- Fair valueUnder review: only one analyst covers it, too few to cross-check it; our model's value is 2.78x the price, above our 2.00x limit.
- Our regime readDistribution, as of 1 Nov 2026
- Ethical screenNot yet scored
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: range not available (screen dated 2026-11-03).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price3.07 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Distribution2.45+25.3% to today Markdown gives way to Distribution after a 47% slide in 3 weeks
2026-10-11Read Markdown4.63-33.7% to today ✓Accumulation gives way to Markdown after an 18% slide in 7 weeks
2026-08-23Read Accumulation5.67-45.9% to today Markup gives way to Accumulation after a 26% slide in 7 weeks
2026-07-02Read Markup7.64-59.8% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Braiin Limited holds its Distribution at $3.07. The statistical read favours the sellers, held for 3 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 3 days |
| Price at the screen | $3.07 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 1.18% | Below 33% | Interest-bearing debt is just 1.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 8.20% | Below 49% | Money owed to the company is 8.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Braiin clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Braiin clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Only one analyst covers it, too few to cross-check it; our model's value is 2.78x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
Price History & ProjectionsWhere our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFresh Aussie farm tech lacks any numbers
Picture a farmer in the outback wiring up sensors and robots to squeeze more from dry soil. Braiin wants to sell that stack of IoT, wireless links and AI across Australia and New Zealand, yet the firm only started in 2022 and still posts zero profit margin.
We pass for the simple reason that no usable financial ratios exist. One analyst target sits at ten dollars against a five-forty-nine price, but without earnings history or a visible moat the margin-of-safety claim stays untested and the ethical screen returns insufficient data.
Risk sits in the complete absence of track record. A young hardware play can burn cash fast when orders fail to appear, and here there are no ratios to judge whether that risk is rising or contained. Analysis, not advice.
| EPS, trailing | -0.14 |
| Profit margin | 0.0%currently unprofitable |
| FCF yield | -0.08% |
| Current ratio | 0.03below 1: short-term bills exceed liquid assets |
| Short interest, float | 0.01% |
| 52-week range | 4.11 - 33.00 |
| Market cap | $847M |
| Employees | 5 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Australia and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBRAI trades on Nasdaq (the company is based in Australia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-01
Distribution · changed $2.45
-40.4% Entry 9
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 40.4% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-10-25
Markdown $4.11
-11.2% Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-10-11
Markdown · changed $4.63
-17.9% Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 17.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-10-02
Accumulation $5.64
-0.5% Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-08-23
Accumulation · changed $5.67
+3.3% Entry 5
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-07-23
Markup $5.49
-28.1% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 28.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-07-18
Markup $7.64
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 27%.
2026-07-03
Markup $7.64
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02
Markup $7.64
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Braiin Ltd. to Participate in AI Panel at 2026 Maxim Growth Summit Yahoo Finance · 23d ago
- Braiin Ltd. to Present at the H.C. Wainwright 28th Annual Global Investment Conference Yahoo Finance · 14 Sep 2026
- Braiin's Agentic AI Targets US$110B+ Global Relocation Market: Company Partners with Muval to Expand into UK and US Yahoo Finance · 29 Jul 2026
- Company News for July 14, 2026 Zacks · 14 Jul 2026
- Company News for July 14, 2026 Yahoo Finance · 14 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
UMACUnusual Machines, Inc.
SSYSStratasys Ltd.
CRSRCorsair Gaming, Inc.
DDD3D Systems Corp
QUBTQuantum Computing Inc.
QMCOQuantum Corp
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $7.21 | +6.9% | · | $1,069 | +6.9% |
| 2 months | $6.72 | +14.7% | · | $1,147 | +14.7% |
| 3 months | $7.22 | +6.8% | · | $1,068 | +6.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BRAI does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.